SS-31 vs Thymosin Alpha-1
Updated November 4, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of SS-31 and Thymosin Alpha-1 (also searched as Thymosin Alpha-1 vs SS-31) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
SS-31 centers on healing, while Thymosin Alpha-1 leans toward inflammation. On indexed research, SS-31 is ahead (SS-31: 37 studies, Human evidence; Thymosin Alpha-1: 21, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •SS-31 is strongest for healing; Thymosin Alpha-1 for inflammation.
- •Evidence: SS-31 Human evidence (37 studies) vs Thymosin Alpha-1 Human clinical (21).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
Mitochondrial protection | Heart and neuro health
Immune modulation | Infections and inflammatory diseases
SS-31 vs Thymosin Alpha-1: side-by-side
| Metric | SS-31 | Thymosin Alpha-1 |
|---|---|---|
| Class | Metabolic | Immune |
| Regulatory status | Research use only | FDA-approved |
| Evidence grade | Human evidence | Human clinical |
| Studies indexed | 37 | 21 |
| Research level | Preclinical | FDA Approved |
| Strongest effect | Healing & recovery | Inflammation & immune |
| Healing & recovery | 4.0▲ | 4.0▲ |
| Muscle & body comp | 2.0▲ | 0.0 |
| Metabolic & appetite | 3.0▲ | 0.0 |
| Neuro & mood | 4.0▲ | 0.0 |
| Sleep & circadian | 1.0▲ | 0.0 |
| Inflammation & immune | 3.0 | 5.0▲ |
| Skin & aesthetics | 1.0▲ | 0.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | SS-31 | Thymosin Alpha-1 |
|---|---|---|
| Mechanism | Cardiolipin binding to stabilize mitochondrial membrane | Enhances T-cell function and promotes maturation of immune cells |
| Route | Subcutaneous injection | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is SS-31?
SS-31, also known as Elamipretide, is a peptide that has garnered attention for its potential role in mitochondrial protection and its implications in various health conditions, particularly those involving oxidative stress and mitochondrial dysfunction.
Full SS-31 profile, mechanism & studies →What is Thymosin Alpha-1?
Thymosin Alpha-1 (Tα1) is a peptide that plays a crucial role in modulating immune responses and has been investigated for its potential therapeutic applications in various conditions, including infections and inflammatory diseases.
Full Thymosin Alpha-1 profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~4.0/5 |
| Muscle | SS-31 | 2.0/5 effect signal |
| Metabolic | SS-31 | 3.0/5 effect signal |
| Neuro | SS-31 | 4.0/5 effect signal |
| Sleep | SS-31 | 1.0/5 effect signal |
| Inflammation | Thymosin Alpha-1 | 5.0/5 effect signal |
| Skin | SS-31 | 1.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack SS-31 and Thymosin Alpha-1?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
SS-31 vs Thymosin Alpha-1: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
SS-31 has 37 approved studies indexed (Human evidence), and Thymosin Alpha-1 has 21 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is SS-31 or Thymosin Alpha-1 better?
It depends on your goal. SS-31 is strongest for healing; Thymosin Alpha-1 for inflammation. SS-31 has more indexed studies (37). See the goal-by-goal breakdown above.
Is SS-31 or Thymosin Alpha-1 better for weight loss?
SS-31 shows the stronger metabolic & appetite profile (3.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is SS-31 or Thymosin Alpha-1 better for muscle?
SS-31 leads on the muscle & body-composition axis (2.0/5).
Which has more research, SS-31 or Thymosin Alpha-1?
SS-31 has 37 approved studies indexed (Human evidence); Thymosin Alpha-1 has 21 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack SS-31 and Thymosin Alpha-1?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of SS-31 vs Thymosin Alpha-1?
SS-31: no community-reported effects logged yet. Thymosin Alpha-1: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is SS-31 or Thymosin Alpha-1 FDA-approved?
SS-31 is a research-use compound and is not FDA-approved. Thymosin Alpha-1 is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Thymosin Alpha-1 better than SS-31?
For inflammation, Thymosin Alpha-1 has the edge; for healing, SS-31 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed November 4, 2026.